Moreover, elevated mRNA expression levels of PLCB1, PLCB2, and PLCB3 were linked to poor OS of every NSCLC patient and were significantly associated with poor prognosis of AC. This evidence concerns the gene PLCB1 and non-small cell lung carcinoma.